NFE2L2 and diabetes mellitus: Altered H3K4 methylation at Keap1 in diabetes is implicated in its gene activation, resulting in restraining Nrf2 in the cytosol; this impairs Nrf2 transcriptional activity and via GCLC-ARE4 reduces GSH biosynthesis [51,85].